- Home
- /
- API
API
API
SMS Pharmaceuticals Ltd is one of the leading pharmaceutical manufacturing companies in India with world-class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards
SMS has over the years developed tremendous manufacturing facilities to suit its style of operations and to meet the requirements of USFDA and WHO cGMP. A total of 4 facilities are being presently operated.
We have capabilities in wide range of APIs / intermediates and have handled varied process reactions and reactor volumes up to 15KL
Our commitment to quality and productivity is reflected in the implementation of total quality management processes at every stage of the manufacturing life cycle which is acknowledged by our ever expanding list of clientele globally.
Vizag Unit
Cool Number
0
KL
Key Products
Ibuprofen, Tenofavir, Ranolazine, Levetiracetam, Lamuvidine, Lamotrigine, Efavirenz, Sitagliptin etc.
Regulatory Approvals
USFDA, KFDA, CDSCO, PMDA
USPs
3 times approved by USFDA.
- Flagship, Multipurpose API manufacturing facility.
- Huge CMO facility to cater highly reputed clients
- Facility aligned for manufacturing niche large-volume molecules.
- Dedicated Ibuprofen largest single -block, single product plant in Asia
- Located at Vizag, spread in an area of over 4,00,000Sq.M
- USFDA (without 483), KFDA, Japan PMDA qualified unit
- 4 main production blocks, with a reactor volume of 464 KL
- Capable of manufacturing 16 products at a time from a mix of 30 products
- Contract manufacturing of retro virals for multinationals
- Facility designed to cater to diverse and specialized CRAMS needs of customers
- All new molecules to be launched from this facility
Bachupally Unit
Cool Number
0
KL
Key Products
Famotidine, Rizatriptan Benzoate, Tadalafil, Sumatriptan Succinate, Itraconazole, Eletriptan HBr etc.
Regulatory Approvals
USFDA, EUGMP, KFDA, CDSCO, PMDA
USPs
5 times approved by USFDA.
- Facility aligned for manufacturing niche small volume molecules.
- One of the largest exporter of Triptans
Bachupally Unit
- Located at Bachupally Area, Hyderabad
- USFDA (Five Times), EDQM ,EUGMP (Germany),KFDA, TGA, Japan PMDA qualified unit
- 4 main production blocks with reactor volume 55 KL
- capable to manufacturing 14 to 15 products
- Facility for niche molecules- Triptans
- Over 200 successful customer audits /visits
Building on our strong capabilities in product development and manufacturing, this unit has developed a wide range of in-house APIs and intermediates.
We focus on chemistry where we can make a difference and combine innovation with efficiency to develop cost-effective and hence affordable processes. We regularly invest in building capacities to ensure reliable and sustained supply.​
We offer our globally compliant cGMP facilities, along with our chemistry expertise, to customers for development and manufacturing of APIs and intermediates. We are already a preferred to several customers, owing to our stringent quality and SHE systems, wide operability range. With proven capabilities, we provide end-to-end API solutions to global markets that meet and exceed the quality, regulatory and requirements as well as cost targets.
INVESTORS DESK